| Jeremy Bass, | |
|
5 Mobile Infirmary Cir, Mobile, AL 36607-3513 | |
| (251) 435-2400 | |
| Not Available |
| Full Name | Jeremy Bass |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 9 Years |
| Location | 5 Mobile Infirmary Cir, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932578069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesiologists Associated Pc | 6204739519 | 361 |
News Archive
Working with fruit flies, Johns Hopkins scientists have decoded the activity of protein signals that let certain nerve cells know when and where to branch so that they reach and connect to their correct muscle targets. The proteins' mammalian counterparts are known to have signaling roles in immunity, nervous system and heart development, and tumor progression, suggesting broad implications for human disease research.
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at CGD, and Denizhan Duran, a research assistant at CGD, note that while the decreases in funding for the Global Health Initiative (GHI) and PEPFAR in President Obama's FY 2013 budget request are "alarming," the "bright spot" is that multilateral programs, including the Global Fund to Fight AIDS, Tuberculosis and Malaria and the GAVI Alliance, would get increases in their funding.
Hypertension in Canada is increasing, and it is projected that more than one-quarter of Canadian adults will be diagnosed with hypertension by 2012/13, according to a study in CMAJ.
Allos Therapeutics, Inc. today announced that it is offering to sell, subject to market and other conditions, 11,000,000 primary shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
The prognosis of pancreatic cancer is poor but new therapies such as gemcitabine have contributed to improving the outcome for patients. Data presented at the 13th European Conference (ECCO) revealed that using the combination of gemcitabine and capecitabine increased overall survival in some patients.
› Verified 8 days ago
| Entity Name | Anesthesiologists Associated Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851371850 PECOS PAC ID: 6204739519 Enrollment ID: O20040202000465 |
News Archive
Working with fruit flies, Johns Hopkins scientists have decoded the activity of protein signals that let certain nerve cells know when and where to branch so that they reach and connect to their correct muscle targets. The proteins' mammalian counterparts are known to have signaling roles in immunity, nervous system and heart development, and tumor progression, suggesting broad implications for human disease research.
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at CGD, and Denizhan Duran, a research assistant at CGD, note that while the decreases in funding for the Global Health Initiative (GHI) and PEPFAR in President Obama's FY 2013 budget request are "alarming," the "bright spot" is that multilateral programs, including the Global Fund to Fight AIDS, Tuberculosis and Malaria and the GAVI Alliance, would get increases in their funding.
Hypertension in Canada is increasing, and it is projected that more than one-quarter of Canadian adults will be diagnosed with hypertension by 2012/13, according to a study in CMAJ.
Allos Therapeutics, Inc. today announced that it is offering to sell, subject to market and other conditions, 11,000,000 primary shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
The prognosis of pancreatic cancer is poor but new therapies such as gemcitabine have contributed to improving the outcome for patients. Data presented at the 13th European Conference (ECCO) revealed that using the combination of gemcitabine and capecitabine increased overall survival in some patients.
› Verified 8 days ago
| Entity Name | Anesthesia Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649265810 PECOS PAC ID: 1557352754 Enrollment ID: O20040518001018 |
News Archive
Working with fruit flies, Johns Hopkins scientists have decoded the activity of protein signals that let certain nerve cells know when and where to branch so that they reach and connect to their correct muscle targets. The proteins' mammalian counterparts are known to have signaling roles in immunity, nervous system and heart development, and tumor progression, suggesting broad implications for human disease research.
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at CGD, and Denizhan Duran, a research assistant at CGD, note that while the decreases in funding for the Global Health Initiative (GHI) and PEPFAR in President Obama's FY 2013 budget request are "alarming," the "bright spot" is that multilateral programs, including the Global Fund to Fight AIDS, Tuberculosis and Malaria and the GAVI Alliance, would get increases in their funding.
Hypertension in Canada is increasing, and it is projected that more than one-quarter of Canadian adults will be diagnosed with hypertension by 2012/13, according to a study in CMAJ.
Allos Therapeutics, Inc. today announced that it is offering to sell, subject to market and other conditions, 11,000,000 primary shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
The prognosis of pancreatic cancer is poor but new therapies such as gemcitabine have contributed to improving the outcome for patients. Data presented at the 13th European Conference (ECCO) revealed that using the combination of gemcitabine and capecitabine increased overall survival in some patients.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeremy Bass, 1 Mobile Infirmary Cir, Floor 2, Mobile, AL 36607-3522 Ph: (251) 435-7990 | Jeremy Bass, 5 Mobile Infirmary Cir, Mobile, AL 36607-3513 Ph: (251) 435-2400 |
News Archive
Working with fruit flies, Johns Hopkins scientists have decoded the activity of protein signals that let certain nerve cells know when and where to branch so that they reach and connect to their correct muscle targets. The proteins' mammalian counterparts are known to have signaling roles in immunity, nervous system and heart development, and tumor progression, suggesting broad implications for human disease research.
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at CGD, and Denizhan Duran, a research assistant at CGD, note that while the decreases in funding for the Global Health Initiative (GHI) and PEPFAR in President Obama's FY 2013 budget request are "alarming," the "bright spot" is that multilateral programs, including the Global Fund to Fight AIDS, Tuberculosis and Malaria and the GAVI Alliance, would get increases in their funding.
Hypertension in Canada is increasing, and it is projected that more than one-quarter of Canadian adults will be diagnosed with hypertension by 2012/13, according to a study in CMAJ.
Allos Therapeutics, Inc. today announced that it is offering to sell, subject to market and other conditions, 11,000,000 primary shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering.
The prognosis of pancreatic cancer is poor but new therapies such as gemcitabine have contributed to improving the outcome for patients. Data presented at the 13th European Conference (ECCO) revealed that using the combination of gemcitabine and capecitabine increased overall survival in some patients.
› Verified 8 days ago
Charles D Young, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-435-7990 | |
Simon M Saliba, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-432-4497 Fax: 251-432-0577 | |
Kerry Coomer, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-435-2400 | |
Emma O'connor, Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-435-2400 | |
Claudia Rey Casanova, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-435-2400 |